Iovance Biotherapeutics Inc. buy Piper Sandler
Start price
20.02.24
/
50%
€11.80
Target price
20.02.25
€16.63
Performance (%)
-53.22%
End price
21.02.25
€5.52
Summary
This prediction ended on 21.02.25 with a price of €5.52. The BUY prediction by Piper_Sandler for Iovance Biotherapeutics Inc. performed very badly with a performance of -53.22%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 3.803% | 3.803% | 21.521% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Piper_Sandler for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Piper Sandler from $14.00 to $18.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten